Rhumbline Advisers Purchases 635 Shares of Select Medical Holdings Co. (NYSE:SEM)

Rhumbline Advisers lifted its stake in Select Medical Holdings Co. (NYSE:SEM) by 0.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 316,502 shares of the health services provider’s stock after acquiring an additional 635 shares during the quarter. Rhumbline Advisers owned 0.24% of Select Medical worth $5,966,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Creative Planning lifted its holdings in Select Medical by 10.6% during the third quarter. Creative Planning now owns 17,441 shares of the health services provider’s stock valued at $608,000 after purchasing an additional 1,665 shares in the last quarter. Sippican Capital Advisors raised its position in shares of Select Medical by 30.9% during the 3rd quarter. Sippican Capital Advisors now owns 12,442 shares of the health services provider’s stock valued at $434,000 after purchasing an additional 2,937 shares during the period. EMC Capital Management lifted its stake in shares of Select Medical by 63.4% during the 3rd quarter. EMC Capital Management now owns 12,536 shares of the health services provider’s stock valued at $437,000 after buying an additional 4,862 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after buying an additional 147,032 shares during the period. Finally, Financial Strategies Group Inc. increased its stake in Select Medical by 22.1% in the 3rd quarter. Financial Strategies Group Inc. now owns 10,709 shares of the health services provider’s stock worth $363,000 after buying an additional 1,938 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SEM has been the topic of several research analyst reports. Royal Bank of Canada lowered their target price on shares of Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a report on Monday. Benchmark upgraded shares of Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Monday. UBS Group reduced their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.25.

Select Medical Price Performance

Shares of SEM opened at $18.50 on Thursday. The business’s 50-day moving average is $19.07 and its two-hundred day moving average is $27.71. The company has a market capitalization of $2.39 billion, a P/E ratio of 11.21, a P/E/G ratio of 0.64 and a beta of 1.45. Select Medical Holdings Co. has a fifty-two week low of $16.20 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.50 billion. Research analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd will be given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is 15.15%.

Insider Transactions at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 17.50% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.